Pubik\u0101cija izdevum\u0101 “Ma\u0123istr\u0101le”, Nr. 12.
Maz ticams, ka tuv\u0101kaj\u0101 laik\u0101 zin\u0101tnieki un farmaceiti izgudros br\u012bnumz\u0101li, kas uz visiem laikiem izgl\u0101bs cilv\u0113ci no vis\u0101m slim\u012bb\u0101m. T\u0101tad, z\u0101les cilv\u0113kiem b\u016bs nepiecie\u0161amas vienm\u0113r. \u0160\u0101d\u0101 situ\u0101cij\u0101 vado\u0161\u0101 farm\u0101cijas uz\u0146\u0113muma Baltijas valst\u012bs AS Grindeks uzdevums ir pied\u0101v\u0101t pacientiem efekt\u012bvus, modernus medikamentus, ar ko uz\u0146\u0113mums veiksm\u012bgi tiek gal\u0101.<\/p>\n\n\n\n
P\u0113d\u0113jo piecu gadu laik\u0101 AS Grindeks invest\u012bcijas infrastrukt\u016bras un ra\u017eo\u0161anas att\u012bst\u012bb\u0101 p\u0101rsniedza 45,53 milj. eiro. 2011. gad\u0101 uz\u0146\u0113mums atv\u0113ris akt\u012bv\u0101s farmaceitisk\u0101s vielas ursodeoksiholsk\u0101bes ra\u017eo\u0161anas iecirkni, k\u0101 ar\u012b atjaunojis vitam\u012bnu ra\u017eo\u0161anu. K\u0101 saka koncerna Grindeks padomes priek\u0161s\u0113d\u0113t\u0101js Kirovs Lipmans, vienm\u0113r j\u0101tiecas p\u0113c liel\u0101kiem pan\u0101kumiem, j\u0101izvirza jauni m\u0113r\u0137i. \u201eApst\u0101ties nedr\u012bkst, it \u012bpa\u0161i \u0146emot v\u0113r\u0101, ka farm\u0101cijas nozare att\u012bst\u0101s \u013coti strauji. \u0160ogad m\u0113s pl\u0101nojam pabeigt zie\u017eu iecirk\u0146a izveidi. Invest\u012bcijas projekt\u0101 sasniedza 1,82 milj. eiro. Uzreiz p\u0113c \u0161\u012b projekta uzs\u0101ksim k\u0101du citu, turpin\u0101sim invest\u0113t att\u012bst\u012bb\u0101,\u201d t\u0101 vi\u0146\u0161.<\/p>\n\n\n\n
Invest\u0113jot ra\u017eo\u0161an\u0101 un att\u012bstot uz\u0146\u0113mumu, Grindeks dom\u0101 ne tikai par sevi, bet par \u0137\u012bmijas un farm\u0101cijas nozares att\u012bst\u012bbu Latvij\u0101 un kopum\u0101 par valsts ekonomiku. \u201eNo t\u0101diem uz\u0146\u0113mumiem k\u0101 Grindeks, kas dod cilv\u0113kiem darbavietas, god\u012bgi maks\u0101 nodok\u013cus, veicina zin\u0101tni, ir atkar\u012bga Latvijas labkl\u0101j\u012bba. T\u0101p\u0113c m\u0113s negaid\u0101m, kam\u0113r tirgus situ\u0101cija izmain\u012bsies, bet pa\u0161i darbojamies pie t\u0101s uzlabo\u0161anos. Katra biznesa m\u0113r\u0137is ir att\u012bst\u012bba, izaugsme, lab\u0101ko rad\u012bt\u0101ju sasnieg\u0161ana, ta\u010du to visu daudz viegl\u0101k pan\u0101kt, kad valst\u012b un re\u0123ion\u0101 ir sak\u0101rtota ekonomisk\u0101 vide, stabila politisk\u0101 un ekonomisk\u0101 situ\u0101cija. Tas ir abpus\u0113js process \u2013 uz\u0146\u0113mumiem j\u0101str\u0101d\u0101 situ\u0101cijas sak\u0101rto\u0161anai, un tad tas sniegs labumu ar\u012b biznesam,\u201d uzskata Kirovs Lipmans, noradot, ka viens no pa\u0146\u0113mieniem, k\u0101 uzlabot valsts ekonomiku un valsts presti\u017eu ir veiksm\u012bgi eksporta projekti. \u201eLatvijai ir vajadz\u012bgs eksports! Tuv\u0101kajos gados viens no svar\u012bg\u0101kajiem Grindeks uzdevumiem \u2013 papla\u0161in\u0101t produktu portfeli, vairot uz\u0146\u0113muma konkur\u0113tsp\u0113ju un, attiec\u012bgi, palielin\u0101t p\u0101rdo\u0161anas apjomus \u0101r\u0113jos tirgos,\u201d saka uz\u0146\u0113muma padomes priek\u0161s\u0113d\u0113t\u0101js.<\/p>\n\n\n\n
Grindeks meitas uz\u0146\u0113mumi str\u0101d\u0101 Igaunij\u0101 \u2013 \u201eTallinas Farmaceitisk\u0101 r\u016bpn\u012bca\u201d, Latvij\u0101 \u2013 \u201eKalceks\u201d un \u201eNamu apsaimnieko\u0161anas projekti\u201d un Krievij\u0101 \u2013 Grindeks Rus, p\u0101rst\u0101vniec\u012bbas un fili\u0101les ir atv\u0113rtas Lietuv\u0101, Igaunij\u0101, Krievij\u0101, Kazahst\u0101n\u0101, Ukrain\u0101, Baltkrievij\u0101, Moldov\u0101, Gruzij\u0101, Azerbaid\u017e\u0101n\u0101 un Uzbekist\u0101n\u0101. Savuk\u0101rt, uz\u0146\u0113muma produkcija tiek eksport\u0113ta ar\u012b uz Rietumeiropas, \u0100zijas un Amerikas tirgiem. \u0160obr\u012bd galvenie Grindeks tirgi ir Krievija un p\u0101r\u0113j\u0101s NVS valstis, Baltijas valstis, V\u0101cija un N\u012bderlande. \u201eLatvija ir mazs tirgus t\u0101dam uz\u0146\u0113mumam k\u0101 Grindeks. Jau vair\u0101ku gadu garum\u0101 m\u016bsu uz\u0146\u0113muma darb\u012bba un biznesa strat\u0113\u0123ija ir orient\u0113ta uz eksportu. Pateicoties tam, esam vado\u0161ais farm\u0101cijas uz\u0146\u0113mums Baltijas valst\u012bs, ar augstu starptautisko atpaz\u012bstam\u012bbu un reput\u0101ciju. Grindeks produkcija tiek eksport\u0113ta uz 50 pasaules valst\u012bm, veidojot 95% no kop\u0113j\u0101 apgroz\u012bjuma,\u201d saka Kirovs Lipmans. \u201eM\u016bsu produkti ir piepras\u012bti \u0101r\u0113jos tirgos, \u012bpa\u0161i \u2013 NVS valst\u012bs. Par to liecina gan p\u0101rdo\u0161anas rezult\u0101ti, gan ar\u012b balvas un atsauksmes, ko sa\u0146emam no sadarb\u012bbas partneriem, \u0101rstiem un pacientiem. T\u0101, 2011. gad\u0101 jaunais Grindeks medikaments Mildron\u0101ts\u00ae<\/small> GX tika atz\u012bts par \u201eLab\u0101ko kardiolo\u0123ijas medikamentu\u201d Ukrain\u0101,\u201d t\u0101 vi\u0146\u0161.<\/p>\n\n\n\n
\u201eViens no m\u016bsu m\u0113r\u0137iem ir gad\u0101 ieviest \u010detras l\u012bdz se\u0161as jaunas gatavo z\u0101\u013cu formas, kas noz\u012bm\u0113, ka nep\u0101rtraukti norit darbs ap 20-30 iestr\u0101d\u0113m, kuras pl\u0101nojam laist tirg\u016b piecu gadu laik\u0101,\u201d pazi\u0146o Kirovs Lipmans, un uzsver, ka sekm\u012bgi kop\u0101 apvienojot akt\u012bvo farmaceitisko vielu un gatavo z\u0101\u013cu formu biznesa iesp\u0113jas, Grindeks priorit\u0101te ir vertik\u0101li integr\u0113ti jeb pilna z\u0101\u013cu izstr\u0101des un ra\u017eo\u0161anas cikla risin\u0101jumi.<\/p>\n","protected":false},"excerpt":{"rendered":"
Pubik\u0101cija izdevum\u0101 “Ma\u0123istr\u0101le”, Nr. 12.Maz ticams, ka tuv\u0101kaj\u0101 laik\u0101 zin\u0101tnieki un farmaceiti izgudros br\u012bnumz\u0101li, kas uz visiem laikiem izgl\u0101bs cilv\u0113ci no vis\u0101m slim\u012bb\u0101m. T\u0101tad, z\u0101les…<\/p>\n","protected":false},"author":3,"featured_media":6601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-952","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/952","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=952"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/952\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/6601"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=952"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=952"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=952"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}